US$ 28.70
glp-1 and inflammation Anti-inflammatory properties of receptor agonists other ancillary benefits from a pharmacological perspective The Therapeutic Potential of GLP-1
Description
Naltrexone/Bupropion ER (Contrave): newly approved treatment option for Chronic Weight Management in obese adults

This decision should always be made with a healthcare provider.

95% CI 1.53 to 18.63

Cukierman-Yaffe T, Gerstein HC, Colhoun HM, Diaz R, Garca-Prez LE, Lakshmanan M, et al

This precision approach helps prioritize which strategiesdietary, behavioral, or pharmacologicalalign best with individual biology

(2017) 60:S394
